Endothelin-1: physiological and pathological roles in myometrium

Area of Science:

• Reproductive biology
• Endocrinology
• Vascular biology

Background:

• Endothelin-1 (ET-1), a peptide hormone, is produced by various tissues, including uterine smooth muscle.
• ET-1 exerts its effects via ETA and ETB receptors, influencing diverse physiological and pathological processes.
• The role of ET-1 in regulating myometrial functions is increasingly recognized, with implications for pregnancy and gynecological disorders.

Purpose of the Study:

• To review the Endothelin (ET) axis and associated signaling pathways governing myometrial contraction.
• To explore the role of ET-1 in myometrial cell proliferation and survival.
• To highlight the significance of ET-1-mediated functions in normal pregnancy, preterm birth, and uterine leiomyoma.

Main Methods:

• Literature review of studies on the ET-1 axis in the myometrium.
• Analysis of signaling pathways involved in ET-1-mediated myometrial functions.
• Synthesis of current knowledge on ET-1's role in pregnancy and uterine pathologies.

Main Results:

• ET-1 significantly influences myometrial contraction, proliferation, and survival through specific signaling cascades.
• The ET-1 axis is implicated in the pathophysiology of preterm birth and uterine leiomyoma.
• Pharmacological targeting of ET-1 receptors is a promising therapeutic strategy for vascular pathologies and cancers.

Conclusions:

• The ET-1 axis is a key regulator of critical myometrial functions.
• Dysregulation of ET-1 signaling contributes to pregnancy complications and uterine diseases.
• Further research into ET-1 pathways may yield novel therapeutic interventions for gynecological conditions.